Literature DB >> 3827211

Effects of beta blockade on contingent negative variation in migraine.

A Maertens de Noordhout, M Timsit-Berthier, M Timsit, J Schoenen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3827211     DOI: 10.1002/ana.410210125

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  6 in total

1.  [Electrophysiological studies on headache: the contingent negative variation].

Authors:  P Kropp; H Göbel; M Dworschak; A Heinze
Journal:  Schmerz       Date:  1996-06-17       Impact factor: 1.107

2.  [Migraine: a disorder of sensory stimulus modulation? Empirical studies based on contingent negative variation.].

Authors:  W D Gerber; P Kropp
Journal:  Schmerz       Date:  1993-12       Impact factor: 1.107

3.  Beta-blocker migraine prophylaxis affects the excitability of the visual cortex as revealed by transcranial magnetic stimulation.

Authors:  Marcus Gerwig; L Niehaus; P Stude; Z Katsarava; H C Diener
Journal:  J Headache Pain       Date:  2011-11-17       Impact factor: 7.277

4.  The enigma of site of action of migraine preventives: no effect of metoprolol on trigeminal pain processing in patients and healthy controls.

Authors:  Julia M Hebestreit; Arne May
Journal:  J Headache Pain       Date:  2017-12-19       Impact factor: 7.277

5.  Topiramate modulates habituation in migraine: evidences from nociceptive responses elicited by laser evoked potentials.

Authors:  Laura Di Clemente; Francesca Puledda; Antonella Biasiotta; Alessandro Viganò; Edoardo Vicenzini; Andrea Truini; Giorgio Cruccu; Vittorio Di Piero
Journal:  J Headache Pain       Date:  2013-03-12       Impact factor: 7.277

6.  Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells.

Authors:  Lars Neeb; Peter Hellen; Jan Hoffmann; Ulrich Dirnagl; Uwe Reuter
Journal:  J Headache Pain       Date:  2016-03-01       Impact factor: 7.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.